Table 11. Evidence of risks associated with CDSS.
| Risks | ||
| Reference ID | Practitioner performance | Patient outcomes |
| Balas 2004 | N/A | +/- |
| Bryan 2008 | N/A | +/- |
| Chaudhry 2006 | N/A | +/- |
| Delpierre 2004 | +/- | +/- |
| Dexheimer, 2008 | N/A | +/- |
| Garg 2005 | N/A | +/- |
| Hayward 2009 | N/A | +/- |
| Heselmans 2009 | N/A | N/A |
| Jamal 2009 | +/- | +/- |
| Jerant, 2000 | +/- | +/- |
| Montgomery 1998 | +/- | - |
| Randell 2007 | - | +/- |
| Shekelle 2006 | N/A | +/- |
| Shiffman 1999 | +/- | +/- |
| Shojania 2009 | N/A | +/- |
| Sintchenko 2007 | +/- | +/- |
| Smith 2007 | N/A | +/- |
| Tan 2009 | +/- | +/- |
Evidence of risks: N/A, not assessed; +/-, none; -, weak; -/- -, weak to moderate; --, moderate.